360 related articles for article (PubMed ID: 29328495)
1. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim IH; Nam TJ
Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495
[TBL] [Abstract][Full Text] [Related]
2. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH
J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657
[TBL] [Abstract][Full Text] [Related]
3. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells.
Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH
BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
5. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol Downregulates Insulin-like Growth Factor-I Receptor and ErbB3 Signaling in HT-29 Human Colon Cancer Cells.
Lee HS; Cho HJ; Kwon GT; Park JH
J Cancer Prev; 2014 Sep; 19(3):161-9. PubMed ID: 25337585
[TBL] [Abstract][Full Text] [Related]
11. Phloroglucinol induces apoptosis through the regulation of insulin-like growth factor 1 receptor signaling pathways in human colon cancer HT-29 cells.
Kang MH; Kim IH; Nam TJ
Int J Oncol; 2014 Sep; 45(3):1036-42. PubMed ID: 24970012
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways.
Han YS; Lee JH; Lee SH
Mol Med Rep; 2015 Sep; 12(3):3446-3452. PubMed ID: 25998232
[TBL] [Abstract][Full Text] [Related]
13. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
Xue M; Ji X; Xue C; Liang H; Ge Y; He X; Zhang L; Bian K; Zhang L
Biomed Pharmacother; 2017 Oct; 94():898-908. PubMed ID: 28810530
[TBL] [Abstract][Full Text] [Related]
14. A polysaccharide of the marine alga Capsosiphon fulvescens induces apoptosis in AGS gastric cancer cells via an IGF-IR-mediated PI3K/Akt pathway.
Kwon MJ; Nam TJ
Cell Biol Int; 2007 Aug; 31(8):768-75. PubMed ID: 17344071
[TBL] [Abstract][Full Text] [Related]
15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
17. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
Zhou W; Rowitz BM; Dailey MJ
Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
[TBL] [Abstract][Full Text] [Related]
18. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells.
Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE
Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway.
Chow JC; Condorelli G; Smith RJ
J Biol Chem; 1998 Feb; 273(8):4672-80. PubMed ID: 9468528
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
